Search for: "ABBOTT LABORATORIES V ANDRX PHARMA" Results 1 - 3 of 3
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Pharma & Biotech Global Week in Review 6 April 2011 from IP Think Tank
6 Apr 2011, 12:18 am by Marie Louise
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Judge Robinson Dismisses Infringement Claims Based on Patents Invalidated in Prior ANDA Litigation Under Doctrine of Collateral Estoppel, Denies Request to Stay Pending Appeal to Fed. Cir.
12 Sep 2012, 1:46 pm by Monté T. Squire
Andrx Pharma, Inc., 473 F.3d 1196, 1203 (Fed. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
IP Think Tank Global Week in Review - 1 August 2008
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog